Young James Emmett
SEC insider (Form 3/4/5 filer). CIK 0002050748. Chief Financial Officer at TriSalus Life Sciences, Inc. (TLSI). 5 reported Form 4/5 transactions since Sep 2024; latest on May 19, 2025. Located in WESTMINSTER, CO.
Companies Young James Emmett has filed insider reports for
- TriSalus Life Sciences, Inc. (TLSI): Officer, Chief Financial Officer
Young James Emmett
CIK: 0002050748
Transaction Breakdown
Open Market Buys (P)2 (40.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TLSI
TriSalus Life Sciences, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 19, 2025TLSI
TriSalus Life Sciences, Inc.
AwardDirect13.2K shares at avg. $5.18$68K - Feb 18, 2025TLSI
TriSalus Life Sciences, Inc.
AwardDirect14.8K shares- - Feb 5, 2025TLSI
TriSalus Life Sciences, Inc.
PurchaseIndirect6K shares at avg. $5.65$34K - Jan 27, 2025TLSI
TriSalus Life Sciences, Inc.
AwardDirect12.5K shares- - Jan 27, 2025TLSI
TriSalus Life Sciences, Inc.
PurchaseIndirect24K shares at avg. $5.40$130K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 19, 2025 | TLSI TriSalus Life Sciences, Inc. | Award | 13,175 | $5.18 | $68,247 | Direct |
| Feb 18, 2025 | TLSI TriSalus Life Sciences, Inc. | Award | 14,762 | - | - | Direct |
| Feb 5, 2025 | TLSI TriSalus Life Sciences, Inc. | Purchase | 6,000 | $5.65 | $33,900 | Indirect |
| Jan 27, 2025 | TLSI TriSalus Life Sciences, Inc. | Award | 12,500 | - | $0 | Direct |
| Jan 27, 2025 | TLSI TriSalus Life Sciences, Inc. | Purchase | 24,000 | $5.40 | $129,600 | Indirect |
1-5 of 5 transactions